-
Transforming Prostate Cancer Care: Insights from Dr. Marie-Pier St-Laurent at ASCO GU
We are thrilled to share an exclusive video featuring the esteemed Dr. Marie-Pier St-Laurent, directly from the ASCO GU conference. Dive deep into the latest breakthroughs in prostate cancer research,…
-
Advancing Prostate Cancer Treatment: Breakthroughs and Strategies with Dr. Neal D. Shore
Welcome to our in-depth Specialist Interview series. In this episode, we’re honored to have Dr. Neal D. Shore from the Carolina Urologic Research Center discuss pivotal advancements in prostate cancer…
-
“CCHIO 2023 | Professor Zhang Jin: Classification Management and Precision Treatment of Breast Cancer Patients”
Breast cancer is the most common malignancy among women globally, with an increasing incidence rate that poses a significant threat to women’s health worldwide. Molecular typing aids in the precise classification and stratified treatment of breast cancer. The continuous development of immunotherapy and targeted therapy offers new treatment options for patients with different types. At…
-
ESMO Hot Topics Update: New Developments in Precision Diagnosis and Treatment with Talazoparib
At this year’s recently concluded ESMO conference, new developments related to the PARP inhibitor talazoparib in precision diagnosis and treatment were announced. Precision diagnosis has become a leading trend in the field of prostate cancer, and biomarker research is receiving increasing attention. In this context, this publication invited Professor Zhang Guiming from Qingdao University Affiliated…
-
Understanding and Managing Chronic Hepatitis B: The Importance of Detailed Assessment
Since the introduction of the first oral nucleos(t)ide analogs (NAs) lamivudine for the treatment of chronic hepatitis B (CHB) in China in 1998, there has been a continuous effort over 25 years to explore various generations of drugs by medical, pharmaceutical, and technological researchers. The NA family has expanded to include entecavir, telbivudine, tenofovir disoproxil…
-
CASH interview | Professor Jinghui Zhang: Monitoring clonal hematopoiesis in pediatric patients to help improve long-term prognosis
Clonal hematopoiesis usually refers to myeloid cell proliferation caused by genetic mutations in hematopoietic stem cells, and is also the basis of the pathogenesis of various blood diseases; monitoring clonal hematopoiesis can enable early detection of hematological malignancies. At the 4th CASH held recently, Professor Jinghui Zhang from St. Jude Children’s Research Hospital shared the…
-
Efficacy and Safety of Crovalimab in Complement Inhibitor-Naive Patients with PNH
Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare and debilitating hematological disease caused by a genetic mutation in the PIG-A gene, resulting in deficient glycosylphosphatidylinositol (GPI) anchor synthesis. This deficiency affects…
Connecting Medical Expertise through Media